| 柯俊龙许志恩△ 何来鹏陈军梁维.舒血宁注射液对脑梗塞患者血小板活化状态的影响[J].,2012,12(2):324-326 |
| 舒血宁注射液对脑梗塞患者血小板活化状态的影响 |
| The Effect of Shuxuening Injection on the Platelet Activation inthe Patient with Cerebral Infraction |
| |
| DOI： |
| 中文关键词: 脑梗塞 血小板活化 舒血宁注射液 |
| 英文关键词: Cerebral infraction Platelet activation Shuxuening Injection |
| 基金项目: |
|
| 摘要点击次数: 1040 |
| 全文下载次数: 1125 |
| 中文摘要: |
| 目的：观察舒血宁注射液（成分：银杏提取物）对脑梗塞患者血小板活化的影响。方法：将63 例脑梗塞患者随机分为两组，其
中拜阿司匹灵组（aspirin group）31 例，单用拜阿司匹灵治疗，舒血宁注射液+ 拜阿司匹灵组（Gingko+aspirin group）32 例，予拜阿
司匹灵联合舒血宁注射液治疗，并设立健康对照组30 名，测定两组脑梗塞患者急性期和恢复期及健康对照组的PAC1、CD62P 表
达率，所测结果进行比较。结果：两组脑梗塞经分别治疗后，舒血宁注射液+ 拜阿司匹灵组PAC1、CD62P 表达率较拜阿司匹灵组
降低，差异有统计学意义（P<0.01）。结论：舒血宁注射液联合拜阿司匹灵可更好的抑制血小板活化。 |
| 英文摘要: |
| Objective: To investigate the effect of Shuxuening Injection （component：Gingko extraction）on cerebral infarction.
Methods: 63 cases of cerebral infarction were randomly divided into two groups, They included 31 cases of bay aspirin group（aspirin
group）,treated with bay aspirin; 32 cases of Shuxuening Injection combination with bay aspirin group （Gingko+aspirin group）, treated
combination with Shuxuening Injection and bay aspirin; and 30 normal persons were served as healthy control group, determine the positive
rate of PAC1, CD62P on the acute stage and recovery stage in the two groups and healthy control group, and researchers were compared.
Results: After treatment respectively, Expression of PAC1 and CD62P in the Shuxuening Injection combination with bay aspirin
group were lower than those in bay aspirin group, suggesting the difference has statistically significant（P<0.01）. Conclusions: Treatment
by Shuxuening Injection combination with bay aspirin can inhibit the platelet activity better. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
